We believe improving hospitality margins, along with the increasing contribution from the commercial portfolio,...
Sharda Cropchem appears to be entering a phase where business fundamentals are improving after...
We upgrade our rating on BAF to BUY with a TP of INR1,300
TIL today represents a classic turnaround story rather than a mature business.
Akash Bhanshali may not seek headlines or television appearances, but his investment track record...
TANFAC appears to be entering a transformational phase supported by large capacity expansions, improving...
Considering the favourable risk-reward profile, we maintain our BUY rating with a target price...
For investors with a higher risk appetite seeking emerging small-cap opportunities linked to India's...
Manipal Health Enterprises (MHEL) is the largest multi-specialty healthcare provider by bed capacity in...
Indo SMC's robust quarterly performance, healthy order inflows, and exposure to structurally growing sectors...